Patent: 7,767,656
✉ Email this page to a colleague
Summary for Patent: 7,767,656
Title: | Blends of temperature sensitive and anionic polymers for drug delivery |
Abstract: | A physical blend of inverse thermal gelling and shear-thinning, thixotropic polymers that has a lower gelation temperature than the thermal gelling polymer alone is provided. The blend results in an injectable hydrogel that does not flow freely at room temperature, but is injectable due to its shear-thinning properties. The thermal-gelling properties of the polymer promote a more mechanically stable gel at body temperature than at room temperature. The polymer matrix gel has inherent therapeutic benefit and can also be used as a drug delivery vehicle for localized release of therapeutic agents. |
Inventor(s): | Shoichet; Molly S (Toronto, Ontario, CA), Gupta; Dimpy (Toronto, Ontario, CA), Tator; Charles H. (Toronto, Ontario, CA) |
Assignee: | |
Application Number: | 11/410,831 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,767,656 |
Patent Claims: | see list of patent claims |
Details for Patent 7,767,656
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Emd Serono, Inc. | PERGONAL | menotropins | For Injection | 017646 | 08/22/1975 | ⤷ Try a Trial | 2025-04-25 |
Emd Serono, Inc. | PERGONAL | menotropins | For Injection | 017646 | 05/20/1985 | ⤷ Try a Trial | 2025-04-25 |
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | HUMEGON | menotropins | For Injection | 020328 | 09/01/1994 | ⤷ Try a Trial | 2025-04-25 |
Ferring Pharmaceuticals Inc. | REPRONEX | menotropins | For Injection | 021047 | 08/27/1999 | ⤷ Try a Trial | 2025-04-25 |
Ferring Pharmaceuticals Inc. | BRAVELLE | urofollitropin | For Injection | 021289 | 05/06/2002 | ⤷ Try a Trial | 2025-04-25 |
Ferring Pharmaceuticals Inc. | MENOPUR | menotropins | For Injection | 021663 | 10/29/2004 | ⤷ Try a Trial | 2025-04-25 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |